Conception is a company developing the technology to turn skin cells into viable human eggs.This technology will give women the opportunity to have children well into their forties and fifties, eliminate barriers for couples suffering from infertility, and potentially allow male-male couples to have biological children.Long term, thistechnology could be a critical platform allowing for widespread genetic screening of embryos. If proven safe, it could even enable for genetic editing to eliminate and reduce the risk of devastating diseases for future generations – such as Alzheimer’s, heart disease and many different types of cancers.This could become one of the most important technologies ever created.The company was founded in 2018 and is headquartered in Berkeley, California.

Health Care

Biotechnology

Conception

Matt Krisiloff

Abbie Groff

Pablo Hurtado González

Bianka Seres

The Research and Stem Cell Biology team at Conception focuses on pioneering the development of technologies to convert skin cells into viable human eggs. This interdisciplinary team conducts cutting-edge research in stem cell biology, cell differentiation, and genetic screening to advance fertility solutions and potential genetic disease elimination. They collaborate to innovate, optimize, and ensure the safety of these groundbreaking reproductive techniques.

Research and Stem Cell Biology

About

Team members

Other teams at Conception

Leadership Team